{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:58:22Z","timestamp":1777111102798,"version":"3.51.4"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The\ncomparative drug dispositions, urinary pharmacokinetics, and effects on\nrenal function of multilamellar liposomal nystatin (LNYS; Nyotran) and\namphotericin B deoxycholate (DAMB; Fungizone) were studied in rabbits.\nDrug concentrations were determined by high-performance liquid\nchromatography as total concentrations of LNYS and DAMB. In comparison\nto a standard dose of 1 mg of DAMB\/kg of body weight, therapeutic\ndosages of LNYS, i.e., 2, 4, and 6 mg\/kg, resulted in escalating\nmaximum concentrations (\n            <jats:italic>C<\/jats:italic>\n            <jats:sub>max<\/jats:sub>\n            ) (17 to 56\u03bc\ng\/ml for LNYS versus 3.36 \u03bcg\/ml for DAMB;\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001) and values for the area under the concentration-time\ncurve from 0 to 24 h (AUC\n            <jats:sub>0-24<\/jats:sub>\n            ) (17 to 77\u03bc\ng\u2009\u00b7\u2009h\/ml for LNYS versus 12\u03bc\ng\u2009\u00b7\u2009h\/ml for DAMB;\n            <jats:italic>P<\/jats:italic>\n            &lt;\n0.001) in plasma but a significantly faster total clearance from plasma\n(0.117 to 0.080 liter\/h\/kg for LNYS versus 0.055 liter\/h\/kg for DAMB;\n            <jats:italic>P<\/jats:italic>\n            = 0.013) and a \u22648-fold-smaller volume of\ndistribution at steady state (\n            <jats:italic>P<\/jats:italic>\n            = 0.002). Urinary drug\nconcentration data revealed a \u226510-fold-higher\n            <jats:italic>C<\/jats:italic>\n            <jats:sub>max<\/jats:sub>\n            (16 to 10 \u03bcg\/ml for LNYS versus 0.96\u03bc\ng\/ml for DAMB;\n            <jats:italic>P<\/jats:italic>\n            = 0.015) and a 4- to\n7-fold-greater AUC\n            <jats:sub>0-24<\/jats:sub>\n            (63 to 35\u03bc\ng\u2009\u00b7\u2009h\/ml for LNYS versus 8.9\u03bc\ng\u2009\u00b7\u2009h\/ml for DAMB;\n            <jats:italic>P<\/jats:italic>\n            =\n0.015) following the administration of LNYS, with a dose-dependent\ndecrease in the dose-normalized AUC\n            <jats:sub>0-24<\/jats:sub>\n            in urine (\n            <jats:italic>P<\/jats:italic>\n            =\n0.001) and a trend toward a dose-dependent decrease in renal\nclearance. Except for the kidneys, the mean concentrations of LNYS in\nliver, spleen, and lung 24 h after dosing were severalfold\nlower than those after administration of DAMB (\n            <jats:italic>P<\/jats:italic>\n            ,&lt;0.002 to &lt;0.001). Less than 1% each of the\ntotal dose of LNYS was recovered from the kidneys, liver, spleen, and\nlungs; in contrast, a quarter of the total dose was recovered from the\nlivers of DAMB-treated animals. LNYS had dose-dependent effects on\nglomerular filtration and distal, but not proximal, renal tubular\nfunction which did not exceed those of DAMB at the highest investigated\ndosage of 6 mg\/kg. The results of this experimental study demonstrate\nfundamental differences in the dispositions of LNYS and DAMB. Based on\nits enhanced urinary exposure, LNYS may offer a therapeutic advantage\nin systemic fungal infections involving the upper and lower urinary\ntracts that require therapy with antifungal\npolyenes.\n          <\/jats:p>","DOI":"10.1128\/aac.47.12.3917-3925.2003","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T22:53:35Z","timestamp":1069714415000},"page":"3917-3925","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":14,"title":["Comparative Drug Disposition, UrinaryPharmacokinetics, and Renal Effects of Multilamellar Liposomal Nystatinand Amphotericin B Deoxycholate inRabbits"],"prefix":"10.1128","volume":"47","author":[{"given":"Andreas H.","family":"Groll","sequence":"first","affiliation":[{"name":"Immunocompromised\rHost Section, Pediatric Oncology Branch, National Cancer\rInstitute"},{"name":"Infectious Disease Research\rProgram, Center for Bone Marrow Transplantation and Department\rof Pediatric Hematology\/Oncology, University Children's\rHospital, Muenster, Federal Republic of\rGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Mickiene","sequence":"additional","affiliation":[{"name":"Immunocompromised\rHost Section, Pediatric Oncology Branch, National Cancer\rInstitute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidmantas","family":"Petraitis","sequence":"additional","affiliation":[{"name":"Immunocompromised\rHost Section, Pediatric Oncology Branch, National Cancer\rInstitute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Petraitiene","sequence":"additional","affiliation":[{"name":"Immunocompromised\rHost Section, Pediatric Oncology Branch, National Cancer\rInstitute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul M.","family":"Alfaro","sequence":"additional","affiliation":[{"name":"Pharmacokinetics Research\rLaboratory, Pharmacy\rDepartment"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"King","sequence":"additional","affiliation":[{"name":"Department of Clinical\rPathology, Warren Grant Magnuson Clinical\rCenter, National Institutes of Health, Bethesda,\rMaryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Piscitelli","sequence":"additional","affiliation":[{"name":"Pharmacokinetics Research\rLaboratory, Pharmacy\rDepartment"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Immunocompromised\rHost Section, Pediatric Oncology Branch, National Cancer\rInstitute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.4.1406-1412.2002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.828-833.2002"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.834-840.2002"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.4.512"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00862587"},{"key":"e_1_3_2_7_2","first-page":"175","volume":"62","year":"1964","unstructured":"Butler, W. T., J. E. Bennett, and D. W. Alling. 1964. Nephrotoxicity of amphotericin B: early and late effects in 81 patients. Ann. Intern. Med.62:175-187.","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.3.397"},{"key":"e_1_3_2_9_2","unstructured":"Committee\non the Care and Use of Laboratory Animals of the Institute of\nLaboratory Animal Resources Commission on Life Sciences National\nResearch Council. 1996. Guide for the care and use of\nlaboratory animals. National Academy Press Washington D.C."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018943613122"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.11.2592"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Gibaldi M. and D. Perrier. 1982. Pharmacokinetics 2nd ed. p. 455-459. Marcel Dekker New York N.Y.","DOI":"10.1201\/b14095"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60129-5"},{"key":"e_1_3_2_14_2","first-page":"95","volume":"43","year":"1999","unstructured":"Groll, A. H., C. E. Gonzalez, N. Giri, K. Kligys, W. Love, J. Peter, E. Feuerstein, J. Bacher, S. C. Piscitelli, and T. J. Walsh. 1999. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety, and non-compartmental pharmacokinetics. J. Antimicrob. Chemother.43:95-103.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(99)00396-5"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.10.2463"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.950-957.2000"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/315643"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2887-2890.2000"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/br.37.2.166-196.1973"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00928-7"},{"key":"e_1_3_2_22_2","first-page":"423","volume":"112","year":"1950","unstructured":"Hazen, E. L., and R. Brown. 1950. Two antifungal agents produced by a soil actinomycete. Science112:423.","journal-title":"Science"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951215)76:12<2557::AID-CNCR2820761223>3.0.CO;2-9"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1412"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(63)90169-3"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01868444"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.5.716"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.713"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.12.1897"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.12.1901"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1264"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199005020-00003"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V62154"},{"key":"e_1_3_2_34_2","unstructured":"Schneider M. 1985. Liposomes as drug carriers: 10 years of\nresearch p. 119-134. In P.\nBuri and A. Gumma (ed.) Drug targeting. Elsevier Science Publishers New York N.Y."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.10.2238"},{"key":"e_1_3_2_36_2","first-page":"467","volume":"38","year":"1988","unstructured":"Walsh, T. J., P. Bacher, and P. A. Pizzo. 1988 . Chronic silastic central venous catheterization for induction, maintenance, and support of persistent granulocytopenia in rabbits. Lab. Anim. Med.38:467-470.","journal-title":"Lab. Anim. Med."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401004"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01575125"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.9.1871"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.2.223"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/313498"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01117450"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.8967"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.12.3917-3925.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.12.3917-3925.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:44:45Z","timestamp":1645465485000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.12.3917-3925.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1128\/AAC.47.12.3917-3925.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.12.3917-3925.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"2003-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}